• Explore /
  • Poster
  • / Multimodal prediction of response to neoadjuvant nivolumab and chemotherapy for surgically resectable stage IIIA non–small cell lung cancer.

Multimodal prediction of response to neoadjuvant nivolumab and chemotherapy for surgically resectable stage IIIA non–small cell lung cancer.

Abstract Poster

Authors

null

Loïc Ferrer

SOPHiA GENETICS, Pessac, France

Loïc Ferrer , Ernest Nadal , Floriane Guidel , Amelia Insa , Philippe Menu , Joaquin Casal , Manuel Domine , Bartomeu Massuti , Margarita Majem , Alex Martinez-Marti , Rosario Garcia Campelo , Javier de Castro Carpeño , Manuel Cobo , Guillermo Lopez Vivanco , Edel del Barco , Reyes Bernabé , Nuria Vinolas , Isidoro Barneto , Thierry Colin , Mariano Provencio-Pulla

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2022 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Lung Cancer—Non-Small Cell Local-Regional/Small Cell/Other Thoracic Cancers

Track

Lung Cancer

Sub Track

Local-Regional Non–Small Cell Lung Cancer

Clinical Trial Registration Number

NCT03838159

Citation

J Clin Oncol 40, 2022 (suppl 16; abstr 8542)

DOI

10.1200/JCO.2022.40.16_suppl.8542

Abstract #

8542

Poster Bd #

169

Abstract Disclosures

Similar Posters

First Author: Samuel Rosner

First Author: Mariano Provencio-Pulla

First Author: David Groheux

First Author: Tina Cascone